Boosting the acceptance of F-FET PET for image-guided treatment planning with a multi-centric prospective trial.
作者信息
Langen Karl-Josef, Galldiks Norbert, Lohmann Philipp, Mottaghy Felix M
机构信息
Institute of Neuroscience and Medicine (INM-3, INM-4), Forschungszentrum Juelich, Juelich, Germany.
Department of Nuclear Medicine, RWTH Aachen University Hospital, Pauwelsstraße 30, D-52074, Aachen, Germany.
出版信息
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3817-3819. doi: 10.1007/s00259-023-06426-7.
Abstract
摘要
相似文献
1
Boosting the acceptance of F-FET PET for image-guided treatment planning with a multi-centric prospective trial.通过一项多中心前瞻性试验提高F-FET PET在图像引导治疗计划中的接受度。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3817-3819. doi: 10.1007/s00259-023-06426-7.
2
[F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.[F]-氟乙基-L-酪氨酸（FET）在胶质母细胞瘤（FIG）TROG 18.06 研究中的应用：一项前瞻性、多中心 PET/CT 试验的方案。
BMJ Open. 2023 Aug 4;13(8):e071327. doi: 10.1136/bmjopen-2022-071327.
3
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.脑胶质瘤的多模态代谢成像：[18F]氟乙基-L-酪氨酸正电子发射断层扫描与磁共振波谱分析
J Neurosurg. 2005 Feb;102(2):318-27. doi: 10.3171/jns.2005.102.2.0318.
4
Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.O-(2-[18F]-氟乙基)-L-酪氨酸-正电子发射断层扫描成像对低级别胶质瘤患者组织病理学特征及无进展生存期的预后价值
World Neurosurg. 2016 May;89:230-9. doi: 10.1016/j.wneu.2016.01.085. Epub 2016 Mar 9.
5
Radiotherapy target volume definition in newly diagnosed high grade glioma using F-FET PET imaging and multiparametric perfusion MRI: A prospective study (IMAGG).使用 F-FET PET 成像和多参数灌注 MRI 对新诊断的高级别胶质瘤进行放射治疗靶区定义：一项前瞻性研究（IMAGG）。
Radiother Oncol. 2020 Sep;150:164-171. doi: 10.1016/j.radonc.2020.06.025. Epub 2020 Jun 21.
6
The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions.18F-FET PET-CT对颅底病变患者图像引导立体定向放射治疗中靶区定义的影响。
Cancer Imaging. 2014 Jun 25;14(1):25. doi: 10.1186/1470-7330-14-25.
7
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.使用 [18F]氟乙基-L-酪氨酸 PET 与 MRI 比较评估贝伐单抗治疗复发性恶性脑胶质瘤患者的疗效。
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):22-33. doi: 10.1007/s00259-012-2251-4. Epub 2012 Sep 29.
8
FET-PET for malignant glioma treatment planning.正电子发射断层扫描-计算机断层扫描融合显像用于恶性胶质瘤治疗计划。
Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30.
9
Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.分析适形放疗治疗脑胶质瘤患者时 FET-PET 成像在靶区勾画中的作用。
Radiother Oncol. 2013 Dec;109(3):487-92. doi: 10.1016/j.radonc.2013.06.043. Epub 2013 Aug 13.
10
(18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.（18）F - 氟乙基 - L - 酪氨酸正电子发射断层扫描用于描绘胶质母细胞瘤切除术后的肿瘤残留：与标准术后磁共振成像的比较
World Neurosurg. 2016 May;89:420-6. doi: 10.1016/j.wneu.2016.02.032. Epub 2016 Feb 15.
本文引用的文献
1
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06.胶质母细胞瘤中 FET PET 生物学体积的勾画和一致性：前瞻性、多中心评估 FET PET 在胶质母细胞瘤中的研究（FIG）-TROG 18.06 核医学认证计划的结果。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3970-3981. doi: 10.1007/s00259-023-06371-5. Epub 2023 Aug 11.
2
Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.基于氨基酸正电子发射断层扫描的脑肿瘤自动检测与分割以评估治疗反应
J Nucl Med. 2023 Oct;64(10):1594-1602. doi: 10.2967/jnumed.123.265725. Epub 2023 Aug 10.
3
Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma.氨基酸 PET 和 MRI 成像相结合可提高成人脑胶质瘤恶性区域的定义准确性。
Nat Commun. 2023 Jul 29;14(1):4572. doi: 10.1038/s41467-023-39731-8.
4
Amino Acid PET in Neurooncology.神经肿瘤学中的氨基酸正电子发射断层扫描
J Nucl Med. 2023 May;64(5):693-700. doi: 10.2967/jnumed.122.264859. Epub 2023 Apr 13.
5
Two Decades of Brain Tumour Imaging with O-(2-[F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience.使用O-(2-[F]氟乙基)-L-酪氨酸PET进行脑肿瘤成像的二十年：于利希研究中心的经验。
Cancers (Basel). 2022 Jul 8;14(14):3336. doi: 10.3390/cancers14143336.
6
Initial Results of a Phase 2 Trial of F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma.F-DOPA PET 引导的剂量递增放疗治疗胶质母细胞瘤的 2 期试验的初步结果。
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1383-1395. doi: 10.1016/j.ijrobp.2021.03.032. Epub 2021 Mar 23.
7
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.正电子发射断层扫描成像对脑胶质瘤患者放疗计划和监测的贡献——PET/RANO 小组的报告。
Neuro Oncol. 2021 Jun 1;23(6):881-893. doi: 10.1093/neuonc/noab013.
8
Early Treatment Response Assessment Using F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy.辅助替莫唑胺化疗后胶质瘤患者 F-FET PET 与对比增强 MRI 早期治疗反应评估。
J Nucl Med. 2021 Jul 1;62(7):918-925. doi: 10.2967/jnumed.120.254243. Epub 2020 Nov 6.
9
Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.基于PET/MR一体机的同时进行的FET-PET和对比增强MRI改善了胶质瘤中肿瘤空间生物分布的描绘：一项活检验证研究。
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1458-1467. doi: 10.1007/s00259-019-04656-2. Epub 2020 Jan 9.
10
PET imaging in patients with brain metastasis-report of the RANO/PET group.脑转移瘤患者的 PET 成像—— RANO/PET 工作组的报告。
Neuro Oncol. 2019 May 6;21(5):585-595. doi: 10.1093/neuonc/noz003.
Zotero 插件